XML 103 R7.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements Of Equity - USD ($)
$ in Thousands
Total
Common Shares [Member]
Common Shares [Member]
Class A Common Shares
Common Shares [Member]
Class B Common Shares
Preferred Shares [Member]
Additional Paid-In Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Distributions in Excess of Net Income [Member]
Total Shareholders' Equity [Member]
Noncontrolling Interests Common Units And LTIP Units [Member]
Total Equity Less Consolidated Joint Venture [Member]
Consolidated Joint Venture [Member]
Beginning Balance (in shares) at Dec. 31, 2016   41,770,514     14,700,000         2,838,546    
Beginning Balance at Dec. 31, 2016 $ 879,739   $ 418 $ 0 $ 147 $ 1,198,311 $ 1,373 $ (364,831) $ 835,418 $ 44,321    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Repurchase of Common Shares (in shares)   (1,991,573)                    
Repurchase of Common Shares (35,178)   (20)     (35,158)     (35,178)      
Dividends and Distributions declared: 0   0     392     392 $ (392)    
Unit Conversion (in shares)   23,964               (23,964)    
Common Units Issued 4,133                 $ 4,133    
Common Units Issued (in shares)                   225,000    
Common Units Issued                        
Preferred Shares (219)         (219)     (219)      
Preferred Shares ATM Issuance, Net of Costs (in shares)         1,700              
Common Units ($1.12 per share)                        
Common Shares (46,241)               (46,241)      
Preferred Shares (24,169)             (24,169) (24,169)      
Common Units (2,270)                 $ (2,270)    
LTIP Units (1,452)                 (1,452)    
Dividend Reinvestment Plan (in shares)   4,425                    
Share Based Compensation: 81         81     81      
Equity Contribution to Consolidated Joint Venture                        
Change in Fair Value of Derivative Instruments     1     28     29 $ 779 $ 808  
Grants (in shares)   109,331               183,784    
Adjustment to Record Noncontrolling Interest at Redemption Value           1,511     1,511 $ 3,935 5,446  
Balance at December 31, 2019             2,376   2,376 160 2,536  
Adjustment to Record Noncontrolling Interest at Redemption Value 0                      
Net Income (Loss) 104,940             99,868 99,868 5,072 104,940  
Ending Balance at Dec. 31, 2017 888,154   399 0 $ 147 1,164,946 3,749 (335,373) 833,868 $ 54,286 888,154 $ 0
Ending Balance (in shares) at Dec. 31, 2017   39,916,661     14,701,700         3,223,366    
Cumulative Effect of Adoption of ASC 610-20 $ 0                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Repurchase of Common Shares (in shares) (635,590) (635,590)                    
Repurchase of Common Shares     (6)     (10,827)     (10,833)   (10,833)  
Dividends and Distributions declared:     1     1,172     1,173 $ (1,173)    
Unit Conversion (in shares) 62,807 62,807               (62,807)    
Common Units Issued                        
Preferred Shares           (128)     (128)   (128)  
Preferred Shares ATM Issuance, Net of Costs (in shares)         1,514              
Common Units ($1.12 per share)                        
Common Shares               (44,119) (44,119)   (44,119)  
Preferred Shares               (24,174) (24,174)   (24,174)  
Common Units                   $ (2,331) (2,331)  
LTIP Units                   $ (1,980) (1,980)  
Dividend Reinvestment Plan (in shares)   4,132                    
Share Based Compensation: $ 77         77     77   77  
Equity Contribution to Consolidated Joint Venture                        
Change in Fair Value of Derivative Instruments     1     997     998   998  
Grants (in shares)   110,616               589,106    
Adjustment to Record Noncontrolling Interest at Redemption Value           2,247     2,247 $ 8,293 10,540  
Noncontrolling Interest, Increase from Subsidiary Equity Issuance                       3,417
Balance at December 31, 2019 516           478   478 38 516  
Adjustment to Record Noncontrolling Interest at Redemption Value (2,708)         (2,708)     (2,708)   (2,708) 2,708
Net Income (Loss) 8,365             12,698 12,698 (916) 11,782 (3,417)
Ending Balance at Dec. 31, 2018 954,815   395 0 $ 147 1,155,776 4,227 (267,740) 892,805 $ 62,010 954,815 2,708
Ending Balance (in shares) at Dec. 31, 2018   39,458,626     14,703,214         3,749,665    
Cumulative Effect of Adoption of ASC 610-20 $ 129,021                      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Repurchase of Common Shares (in shares) (933,436) (933,436)                    
Repurchase of Common Shares     (9)     (14,277)     (14,286)   (14,286)  
Unit Conversion (in shares) 0                      
Common Units ($1.12 per share)                        
Common Shares               (43,600) (43,600)   (43,600)  
Preferred Shares               (24,174) (24,174)   (24,174)  
Common Units                   $ (2,314) (2,314)  
LTIP Units                   $ (2,601) (2,601)  
Dividend Reinvestment Plan (in shares)   3,760                    
Share Based Compensation: $ 60         60     60   60  
Equity Contribution to Consolidated Joint Venture                        
Change in Fair Value of Derivative Instruments     1     675     676   676  
Grants (in shares)   123,700               530,281    
Adjustment to Record Noncontrolling Interest at Redemption Value           3,062     3,062 $ 9,693 12,755  
Noncontrolling Interest, Increase from Subsidiary Equity Issuance                       300
Balance at December 31, 2019 (3,495)           (3,217)   (3,217) (278) (3,495)  
Adjustment to Record Noncontrolling Interest at Redemption Value (488)         (488)     (488)   (488) 488
Net Income (Loss) (5,847)             (3,181) (3,181) (2,366) (5,547) (300)
Ending Balance at Dec. 31, 2019 871,801   $ 387 $ 0 $ 147 $ 1,144,808 $ 1,010 $ (338,695) $ 807,657 $ 64,144 $ 871,801 $ 3,196
Ending Balance (in shares) at Dec. 31, 2019   38,652,650     14,703,214         4,279,946    
Cumulative Effect of Adoption of ASC 610-20 $ 0